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140Retinal Vasculometry Associations With
Glaucoma: Findings From the European
Prospective Investigation of Cancer–Norfolk Eye
StudyALICJA R. RUDNICKA, CHRISTOPHER G. OWEN, ROSHAN A. WELIKALA, SARAH A. BARMAN,
PETER H. WHINCUP, DAVID P. STRACHAN, MICHELLE P.Y. CHAN, ANTHONY P. KHAWAJA,
DAVID C. BROADWAY, ROBERT LUBEN, SHABINA A. HAYAT, KAY-TEE KHAW, AND PAUL J. FOSTER PURPOSE: To examine retinal vasculometry associa-
tions with different glaucomas in older British people.
 DESIGN: Cross-sectional study.
 METHODS: A total of 8,623 European Prospective
Investigation into Cancer-Norfolk Eye study participants
were examined, who underwent retinal imaging, ocular
biometry assessment, and clinical ascertainment of ocular
hypertensive or glaucoma status (including glaucoma sus-
pect [GS], high-tension open-angle glaucoma [HTG], and
normal-tension glaucoma [NTG]). Automated measures
of arteriolar and venular tortuosity, area, and width
from retinal images were obtained. MAIN OUTCOME MEA-
SURES: Associations between glaucoma and retinal vascul-
ometry outcomes were analyzed using multilevel linear
regression, adjusted for age, sex, height, axial length,
intraocular and systemic blood pressure, and within-
person clustering, to provide absolute differences in width
and area, and percentage differences in vessel tortuosity.
Presence or absence of within-person-between-eye differ-
ences in retinal vasculometry by diagnoses were
examined.
 RESULTS: A total of 565,593 vessel segments from
5,947 participants (mean age 67.6 years, SD 7.6 years,
57% women) were included; numbers with HTG,
NTG, and GS in at least 1 eye were 87, 82, and 439,
respectively. Thinner arterioles (L3.2 mm; 95% confi-
dence interval [CI] L4.4 mm, L1.9 mm) and venulesupplemental Material available at AJO.com.
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CROWN COPYRIGHT © 2020 P(L2.7 mm; 95% CI L4.9 mm, L0.5 mm) were associ-
ated with HTG. Reduced venular area was associated
with HTG (L0.2 mm2; 95%
CI L0.3 mm2, L0.1 mm2) and NTG (L0.2 mm2;
95% CI L0.3 mm2, L0.0 mm2). Less tortuous retinal
arterioles and venules were associated with all glaucomas,
but only significantly for GS (L3.9%; 95%
CI L7.7%, L0.1% and L4.8%; 95%
CI L7.4%, L2.1%, respectively). There was no evi-
dence of within-person-between-eye differences in retinal
vasculometry associations by diagnoses.
 CONCLUSIONS: Retinal vessel width associations with
glaucoma and novel associations with vessel area and tor-
tuosity, together with no evidence of within-person-
between-eye differences in retinal vasculometry, suggest
a vascular cause of glaucoma. (Am J Ophthalmol
2020;220:140–151. Crown Copyright  2020
Published by Elsevier Inc. This is an open access article
under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).)
G
LAUCOMA IS THE LEADING GLOBAL CAUSE OF
irreversible visual impairment1 and a common
cause of registered blindness.2 Glaucoma includes
a heterogeneous group of diseases that result in optic neu-
ropathy and progressive retinal ganglion cell degeneration,
leading to visual loss.3 Primary open-angle glaucoma
(POAG) is the most common type of glaucoma, account-
ing for three-quarters (74%) of all glaucoma cases.4 A
recent review estimated the global number of POAG cases
in 2020 to be 66million, and predicted to rise owing to pop-
ulation aging.5 Elevated intraocular pressure (IOP) is the
major modifiable risk factor for glaucoma. Pharmaceutical
and/or surgical intervention to reduce IOP offers the
accepted and only proven form of management.6–8
However, these management strategies to reduce IOP are
not universally effective. Hence the exact etiology and
therapeutic target for glaucoma remains unclear. Retinal
vasculometry associations with glaucoma9 and associations
of glaucoma with other vascular-related outcomes,
including diabetes and cardiovascular events, suggests a0002-9394
https://doi.org/10.1016/j.ajo.2020.07.027
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vasculogenesis.10–12 However, it is unclear whether retinal
vascular changes (particularly retinal arteriolar
thinning)13,14 are a cause or consequence of glaucomatous
retinal nerve fiber layer (RNFL) atrophy, particularly as ev-
idence from longitudinal studies has been mixed.15,16
Moreover, whether other morphometric vascular changes
beyond vessel thinning (including novel measures of vessel
tortuosity and area, which have been little studied to date),
of arterioles, venules, or both,9,13,14,17 are equally or differ-
ently indicative of the disease.18
We used a fully automated retina vasculometry system
(QUARTZ) to examine associations with glaucoma in a
large population of older British men and women, who
took part in the European Prospective Investigation into
Cancer (EPIC) Norfolk Eye study.19 The study allowed as-
sociations previously observed with retinal vessel width to
be confirmed and to also examine novel associations with
measures of vessel tortuosity and vessel area, providing
the opportunity to further characterize the epiphenomenon
of retinal vessel changes associated with glaucoma. Because
the retinal vessels do not supply the anterior chamber of the
eye, an association between retinal vascular morphology
and glaucomatous disease could arise either as a conse-
quence of raised IOP or because the retinal vessels reflect
systemic changes in the microvasculature that are part of
the causal pathway leading to glaucomatous retinal gan-
glion cell death independently of IOP. In this paper we
also present an innovative analytic approach of examining
within-person-between-eye correlations between IOP and
retinal vascular morphology to provide further evidence
(in the absence of consistent evidence from longitudinal
studies) of whether retinal changes are a cause or conse-
quence of glaucomatous disease.METHODS
 STUDYPOPULATION: The EPIC study is a pan-European
cohort study designed to investigate the causes of major
chronic diseases.20 EPIC-Norfolk was the UK component
of the study, and at baseline (from 1993 to 1997) recruited
25,639 participants (99.7% white European, aged 40-79
years) from 35 general practices in and around the city of
Norfolk.21,22 Study participants had a detailed examination
(including anthropometry, blood pressure, and urine and
venous blood sampling) and questionnaire assessment at
entry (including information on pre-existing cardiovascu-
lar disease, type 2 diabetes, and other medical conditions)
and completed periodic questionnaires about their health
(with a particular focus on dietary habits and smoking sta-
tus). Participants underwent multiple clinical assessments,
including repeat anthropometric assessment, venous blood
sampling, retinal imaging (the EPIC Norfolk Eye Study)
and physiological measures.22VOL. 220 RETINAL VASCULOMETRY ASSOC EPIC NORFOLK EYE STUDY: Between 2004 and 2011 at
the third clinical follow-up assessment, 8,623 participants
provided updated information on medical history and life-
style behavior.23 The study was carried out following the
principles of the Declaration of Helsinki and the Research
Governance Framework for Health and Social Care. The
study was approved by the Norfolk Local Research Ethics
Committee (05/Q0101/191) and East Norfolk and Wave-
ney NHS Research Governance Committee
(2005EC07L). All participants gave written, informed con-
sent. Weight and height were measured with participants
in light clothing without shoes. Weight was measured to
the nearest 0.1 kg using regularly calibrated digital scales
(Tanita TBF-300; Tanita UK Ltd, Middlesex, UK) and
height to the last complete 0.1 cm using a stadiometer
(Chasmors, London, UK). Body mass index (BMI) was
calculated as weight/height squared in kg/m2. Seated blood
pressure was measured twice using an automated blood
pressure monitor (Accutorr Plus; Datascope Patient Moni-
toring, Huntington, UK); the mean of both measures was
used. A nonfasting venous blood sample was collected; de-
tails of the analytic measures have been published previ-
ously.22 HbA1c was measured in whole blood using high-
performance liquid chromatography. Serum total choles-
terol and HDL-cholesterol were measured using an auto-
analyzer (RA 1000 Technicon; Bayer Diagnostics, Basing-
stoke, UK); LDL-cholesterol was calculated using the
Fredrickson–Friedewald equation.24
 OCULAR ASSESSMENT: Ophthalmic tests included mea-
surement of vision, visual acuity (logMAR acuity), and
closed-field autorefraction (Humphrey model 500;
Humphrey Instruments, San Leandro, California, USA),
which was used to estimate axial length. Noncontact
tonometry (using the AT555 and Ocular Response
Analyzer; Reichert Corporation, Philadelphia, Pennsylva-
nia, USA) provided gold-standard Goldmann-correlated
IOP (mm Hg), as well as a measure of corneal hysteresis
(to provide a corneal-compensated IOP).25 Scanning laser
ophthalmoscopy of the optic nerve head (Heidelberg
Retina Tomograph–HRT II, Heidelberg Engineering, Hei-
delberg, Germany) and polarimetry of the peripapillary
nerve fiber layer (GDx VCC; Zeiss, Dublin, California,
USA) were used to assess glaucomatous status. A 24-2 cen-
tral threshold visual field test (Humphrey 750i Visual Field
Analyzer; Carl Zeiss Meditec, Welwyn Garden City, UK)
was carried out in those with abnormal imaging and in
10% of those with normal findings.
 GLAUCOMA DIAGNOSIS: Glaucoma was defined as hav-
ing structural abnormalities of the optic disc and visual field
loss, in the absence of any other explanation.26 Higher-
tension POAG and normal-tension glaucoma (NTG)
were differentiated by pretreatment IOP (where median
IOP >22 mm Hg determined high-tension glaucoma
[HTG]). Glaucoma suspect (GS) was defined as the141IATIONS WITH GLAUCOMA
presence of early or minor glaucomatous disc features, asso-
ciated with a normal visual field or the absence of visual
field data. Those with IOP>21 mmHg without visual field
loss or optic disc abnormality were defined as ocular hyper-
tensive (OHT). Specific quantitative methods and princi-
ples for diagnosis of glaucoma, GS, and OHT status
followed the diagnostic principles from the International
Society of Geographical and Epidemiological Ophthal-
mology.26 To limit false-positive or false-negative results,
another consultant glaucoma ophthalmologist (P.J.F.)
reviewed all examination findings and history in a subset
of high-risk participants.27
 FUNDUS IMAGING AND IMAGE PROCESSING: Macular-
centered 45-degree digital fundus photographs were taken
using a TRC-NW6S nonmydriatic retinal camera and
IMAGEnet Telemedicine System (Topcon Corporation,
Tokyo, Japan) with a 10 megapixel Nikon D80 camera
(Nikon Corporation, Tokyo, Japan) without pharmaco-
logic dilation of the pupil. Image processing was carried
out using an automated computerized vasculometry system
(Quantitative analysis of retinal vessel topology and size;
QUARTZ).28–31 The QUARTZ system obtained
thousands of measures of width and tortuosity from the
whole retinal image (dependent on image quality), not
just concentric areas centered on the disc (Supplemental
Figure 1; Supplemental Material available at AJO.com).
The QUARTZ measures were summarized using mean
vessel segment width in micrometers and tortuosity with
arbitrary units,19 weighted by the length of the vessel
segment, for arterioles and venules separately for each im-
age; mean segment widths and lengths were summed to
calculate arteriolar and venular area in mm.2 A previously
validated tortuosity measure that shows good agreement
with subjective assessment of vessel tortuosity, based on
the mean change in chord length between successive divi-
sions of the vessel, was used.19 Automated image quality
assessment allowed the best image per individual to be
used. System performance had been validated previously
and allowed fully automated batch processing of images
from large population-based studies.28–31 A model eye
was used to quantify the magnification characteristics of
the imaging system used, allowing pixel dimensions of
vessel width to be converted to real size.32
 STATISTICAL ANALYSIS: Statistical analyses were car-
ried out using STATA software (version 15; StataCorp
LP, College Station, Texas, USA). Histograms of retinal
vessel widths and area showed normal distributions, while
measures of tortuosity were positively skewed and log-
transformed. Multilevel linear regression models adjusting
for age and sex were used to examine associations of prev-
alent glaucoma status for each eye in relation to retinal
vessel measures for the corresponding eye. Eye-level as
opposed to person-level glaucoma diagnoses were consid-
ered a priori to assess local vasculometry associations, to142 AMERICAN JOURNAL OFallow for between-eye differences in glaucoma diagnoses
within the same individual. A random effect for person
was included in all regression models to allow for the right-
and left-eye data from the same person to contribute to the
analyses. Regression models provided mean differences in
width (mm) and area (mm2) and percentage differences
in tortuosity (as log transformed) for venules and arterioles
separately for each type of glaucoma compared with those
without a diagnosis of glaucoma. Models were adjusted
for (1) age and sex (Model 1), followed by additional
adjustment for (2) stature (ie, height), ocular biometry
(ie, axial length), and factors related to ocular hemody-
namics (corneal-compensated IOP and systolic blood pres-
sure; Model 2); and (3) smoking status (never, former,
current) and cardiometabolic risk factors (including total
cholesterol, HbA1c, and BMI; Model 3). Model 2 was
used as the primary association, given independence from
IOP and blood pressure, which show strong associations
with retinal vasculometry.33 Sensitivity analyses examined
the effect of excluding participants with self-reported heart
attack, stroke, type 2 diabetes, and hypertension.
Between-Person Analyses. Among individuals with
retinal images from both eyes and with the same diagnosis
in each eye, we examined cross-sectional associations
between vasculometric measures and IOP to assess the
consistency of this relationship among those with and
without a glaucoma diagnosis.
Within-Person-Between-Eye Analyses. We examined
within-person-between-eye differences in retinal vessel
measures in relation to within-person-between-eye
differences in IOP and specifically among individuals with
a different diagnosis between eyes. Although IOP is a
modifiable risk factor for glaucoma, it is not a defining
feature, akin to high blood pressure being a modifiable risk
factor for coronary heart disease. However, within-person-
between-eye asymmetry in IOP generally relates to severity
of glaucoma, in that the eye with the higher IOP usually
shows more advanced disease.34–36 Hence, at the person
level asymmetry in IOP could be used as a marker of
asymmetry in disease severity (rather than a defining
feature of the disease itself). Similarly, within-person-
between-eye asymmetry in glaucoma diagnosis provides
another within-person marker of asymmetry in disease
type/severity. Within-person-between-eye asymmetry in
IOP or glaucoma diagnosis could then be used to explore
within-person-between-eye asymmetry in retinal
vasculometry. A major advantage of this approach is that
within-person-between-eye analyses would be self-
controlled for systemic cardiovascular risk factors, lifestyle,
medications and other unmeasured confounders. If within-
person-between-eye asymmetry glaucoma severity is in part
due to a local ocular pathway, then within-person-
between-eye asymmetry in retinal vasculometry might
occur as a consequence of local ocular pathogenicDECEMBER 2020OPHTHALMOLOGY
FIGURE 1. Pathways by which local and systemic factors may influence retinal vasculometry comparisons between eyes.mechanisms. However, if the effect on the retinal
vasculometry is not influenced by local ocular mechanisms
but instead is influenced by factors higher upstream (ie,
systemic factors), then within-person-between-eye
asymmetry in retinal vasculometry would not be observed.
Hence, absence of an association of within-person-
between-eye differences in IOP or glaucoma diagnosis with
within-person-between-eye differences in retinal
vasculometry would suggest that any differences in vessel
characteristics are unlikely to be a consequence of the
disease process occurring within the eye but potentially a
precursor, on the causal pathway, or indicative of other
systemic causes. However, limitations of sample size need
to be acknowledged, in that there may be insufficient
power to detect within-person-between-eye differences in
association and large studies are needed to mitigate against
this. These 2 hypotheses are illustrated by pathway
diagrams in Figure 1. As far as we are aware, we are the first
to use within-person-between-eye differences in retinal
vasculometry by glaucoma diagnosis, to provide further
evidence (but not absolute proof) of whether retinal vessel
changes are a cause or consequence of glaucomatous disease.VOL. 220 RETINAL VASCULOMETRY ASSOCRESULTS
IN TOTAL 8,623 INDIVIDUALS PARTICIPATED IN THE EPIC
Norfolk Eye Study (mean age 68 years, 57% women), of
18,380 invited (participation rate 47%). Characteristics
of EPIC Norfolk participants who took part in the Eye
Study with and without usable fundus images have been
described previously.23 Those taking part were younger at
baseline, were of higher BMI and socioeconomic status,
and were less likely to be a current smoker compared to par-
ticipants not followed up.23 Of the 7,411 individuals who
underwent fundus imaging and refractive assessment,
5,947 (80%) had a fundus image from at least 1 eye of suf-
ficient quality for analysis. Images excluded were mis-
centered, defocused, or obstructed by lashes and/or media
opacities. Participant characteristics of the 5,947 included
and 2,676 excluded from the vasculometry analyses are
summarized in Table 1. Characteristics were similar, except
those included were younger (67.6 years vs 71.3 years) and
more likely to be women (57% vs 51%). The prevalences of
HTG, NTG, GS, and OHT in at least 1 eye among the
5,947 participants included were 1.5% (n ¼ 87), 1.4%143IATIONS WITH GLAUCOMA
TABLE 1. Participant Characteristics of EPIC Study Participants who Took Part in the Third Health Check With and Without Useable
Fundus Images
Characteristic Included in the Analyses Excluded from the Analyses
Total number 5,947 2,676
Age (y), mean (SD) 67.6 (7.6) 71.3 (8.6)
Sex, n (% female) 3,393 (57.1) 1,369 (51)
Current smoker, n (%) 267 (4.5) 105 (4)
Former smoker, n (%) 2,628 (44.2) 1,281 (48)
Height (cm), mean (SD) 166.4 (9.1) 166.2 (9.2)
Weight (kg), mean (SD) 74.4 (14.3) 74.6 (14.0)
BMI (kg/m2), mean (SD) 26.8 (4.3) 27.0 (4.2)
Systolic blood pressure (mm Hg), mean (SD) 135.7 (16.6) 137.2 (16.8)
Diastolic blood pressure (mm Hg), mean (SD) 78.4 (9.2) 77.9 (9.6)
Self-reported heart attack, n (%) 187 (3.1) 106 (4.0)
Self-reported stroke, n (%) 118 (2.0) 67 (2.5)
Self-reported type 2 diabetes, n (%) 237 (4.0) 156 (5.8)
Self-reported hypertension, n (%) 1,757 (29.5) 869 (32.5)
Ocular measures, mean (SD)
Axial length OD (mm) 23.6 (1.2) 23.5 (1.2)
Axial length OS (mm) 23.5 (1.2) 23.5 (1.3)
Mean best vision sphere OD (D) 0.1 (2.2) 0.2 (2.5)
Mean best vision sphere OS (D) 0.2 (2.3) 0.3 (2.4)
IOPg OD (mm Hg) 16.1 (3.9)
IOPg OS (mm Hg) 16.9 (3.9)
IOPcc OD (mm Hg) 16.1 (3.8)
IOPcc OS (mm Hg) 16.8 (3.9)
Arteriolar width OD (mm) 74.9 (6.9)
Arteriolar width OS (mm) 74.8 (6.7)
Venular width OD (mm) 91.5 (11.3)
Venular width OS (mm) 90.3 (11.9)
Arteriolar area OD (mm2) 2.0 (0.8)
Arteriolar area OS (mm2) 2.0 (0.8)
Venular area OD (mm2) 2.6 (0.7)
Venular area OS (mm2) 2.7 (0.7)
Arteriolar tortuosity OD 3 1,000a 4.2 (1.6)
Arteriolar tortuosity OS 3 1,000a 4.3 (1.6)
Venular tortuosity right 3 1,000a 3.1 (1.4)
Venular tortuosity left 3 1,000a 3.3 (1.4)
D ¼ diopters; GS ¼ glaucoma suspect; HTG ¼ high-tension open-angle glaucoma; IOPcc ¼ corneal-compensated intraocular pressure;
IOPg ¼ Goldmann-correlated intraocular pressure; NTG ¼ normal-tension glaucoma.
For participants included in the analyses best vision sphere missing for 27 participants.
aGeometric mean (GSD).(n ¼ 82), 7.4%, (n ¼ 439), and 10.8% (n ¼ 642), respec-
tively. In total, measures of vessel width and tortuosity for
565,593 vessel segments (279,802 arterioles, 285,791 ve-
nules) from 10,466 eyes were included in the analyses.
Eye-specific retinal vasculometry, IOP, and ocular biom-
etry measures in those with usable fundus images are sum-
marized in Table 1 for arterioles and venules separately,
which overall appeared similar for right and left eyes.
Mean arteriolar width was 74.9 mm (standard deviation
[SD] 6.8 mm), venular width was 90.9 mm (SD 11.5 mm);
corresponding measures of vessel area were 2.0 mm2 (SD144 AMERICAN JOURNAL OF0.7 mm2) and 2.7 mm2 (SD 0.7 mm2), tortuosity 4.2 3
103 (GSD 1.6 3 103) and 3.2 3 103 (GSD 1.4 3
103), respectively, so arterioles were thinner (by
15 mm), less dense (by 26%), and more tortuous (by
40%) than venules.
Cross-sectional associations between eye-level retinal
vessel measures and ocular diagnoses are shown in
Table 2. Allowing for factors related to hemodynamics
(IOP and systolic blood pressure) and biometry (axial
length and height–Model 2), eyes with a diagnosis of
HTG had on average narrower arterioles (by 3.2 mm,DECEMBER 2020OPHTHALMOLOGY
TABLE 2. Adjusted Differences in Vessel Width and Tortuosity Associated With an Ocular Diagnosis of Glaucoma Compared With Those Without a Diagnosis of Glaucoma
Diagnosis
Absolute Difference in Arteriolar Width, mm (95% CI) Absolute Difference in Venular Width, mm (95% CI)
Model 1 P Value Model 2 P Value Model 3 P Value Model 1 P Value Model 2 P Value Model 3 P Value
HTG 2.41 (3.69, 1.12) <.001 3.17 (4.43, 1.92) <.001 3.75 (5.08, 2.41) <.001 2.67 (4.82, 0.53) .015 2.70 (4.89, 0.51) .016 3.64 (5.95, 1.32) .002
NTG 1.22 (2.54, 0.09) .068 2.12 (3.41, 0.83) .001 1.75 (3.10, 0.39) .011 1.03 (3.23, 1.16) .356 1.06 (3.29, 1.18) .353 1.25 (3.60, 1.10) .298
GS 0.36 (0.22, 0.94) .226 0.22 (0.80, 0.36) .454 0.22 (0.83, 0.39) .478 0.24 (1.21, 0.73) .630 0.38 (1.39, 0.63) .466 0.61 (1.67, 0.45) .258
OHT 0.13 (0.34, 0.60) .585 0.32 (0.82, 0.18) .212 0.32 (0.84, 0.21) .240 0.13 (0.66, 0.91) .754 0.05 (0.81, 0.91) .913 0.03 (0.93, 0.87) .948
Absolute Difference in Arteriolar Area, mm2 (95% CI) Absolute Difference in Venular Area, mm2 (95% CI)
HTG 0.04 (0.18, 0.10) .554 0.07 (0.21, 0.07) .296 0.09 (0.24, 0.06) .217 0.10 (0.23, 0.03) .116 0.21 (0.34, 0.09) .001 0.16 (0.29, 0.03) .015
NTG 0.09 (0.23, 0.05) .207 0.09 (0.23, 0.06) .241 0.10 (0.25, 0.05) .183 0.05 (0.18, 0.08) .429 0.15 (0.28, 0.02) .022 0.12 (0.25, 0.01) .081
GS 0.01 (0.08, 0.05) .650 0.03 (0.09, 0.04) .370 0.04 (0.11, 0.02) .198 0.04 (0.02, 0.10) .156 0.02 (0.08, 0.03) .415 0.03 (0.09, 0.03) .399
OHT 0.04 (0.02, 0.09) .170 0.00 (0.06, 0.05) .981 0.01 (0.05, 0.07) .696 0.01 (0.03, 0.06) .561 0.03 (0.08, 0.02) .282 0.02 (0.07, 0.03) .417
% Difference in Arteriolar Tortuosity (95% CI) % Difference in Venular Tortuosity (95% CI)
HTG 2.41 (10.31, 6.19) .571 2.21 (10.30, 6.60) .611 3.77 (12.19, 5.44) .410 5.64 (11.04, 0.09) .053 4.59 (10.17, 1.34) .126 3.48 (9.47, 2.91) .279
NTG 4.73 (12.49, 3.72) .264 4.95 (12.85, 3.66) .251 5.52 (13.85, 3.61) .227 2.90 (8.64, 3.19) .342 2.81 (8.66, 3.42) .369 2.58 (8.75, 4.01) .434
GS 2.80 (6.44, 0.97) .144 3.94 (7.67, 0.06) .046 4.77 (8.67, 0.70) .022 4.83 (7.35, 2.26) <.001 4.79 (7.42, 2.10) .001 4.81 (7.56, 1.98) .001
OHT 1.54 (4.41, 1.43) .306 1.73 (4.83, 1.46) .284 1.09 (4.36, 2.29) .522 1.57 (3.73, 0.64) .162 1.56 (3.96, 0.89) .211 0.87 (3.41, 1.73) .507
GS ¼ glaucoma suspect; HTG ¼ high-tension open-angle glaucoma; NTG ¼ normal-tension glaucoma; OHT ¼ ocular hypertension.
Adjusted differences are from amultilevel model allowing for repeated images from the same person (random effect for person). Model 1 (N¼ 5,947) adjusted for age, sex as fixed effects; Model
2 ¼Model 1 þ corneal-compensated intraocular pressure, systolic blood pressure, height, axial length; Model 3 ¼Model 2 þ smoking status, total cholesterol, body mass index, and HbA1c. The
sample size reduction due to missing data in Model 2 N ¼ 5,742, Model 3 N ¼ 5,204
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FIGURE 2. Demonstration of QUARTZ output showing narrow arterioles in the superior arcade of a patient with high-tension glau-
coma (HTG) (B) and narrow venules in another patient with HTG (C), compared with a healthy subject (A).95% confidence interval [CI] 4.4 mm, 1.9 mm) and
narrower venules (2.7 mm, 95% CI 4.9 mm, 0.5 mm;
these effect sizes remained similar after adjustment for
cardiometabolic risk factors (Model 3), perhaps becoming
a little stronger (3.8 mm, 95%
CI 5.1 mm, 2.4 mm; 3.6 mm, 95%
CI 6.0 mm, 1.3 mm, respectively). These associations
are demonstrated visually in Figure 2, which shows
narrower arterioles in the superior retinal vessel arcade of
a patient with HTG (middle panel) and narrow venules
in another patient with HTG (lower panel), compared
with a healthy subject (upper panel).
NTG showed similar directions of association with vessel
width, but were less in magnitude, only being statistically
significant in Models 2 and 3 for arteriolar width
(2.1 mm, 95% CI 3.4 mm, 0.8 mm; 1.8 mm, 95%
CI 3.1 mm, 0.4 mm, respectively). Reduced venular
area was associated with both HTG (0.2 mm2, 95%
CI 0.3 mm2, 0.1 mm2) and NTG (0.2 mm2, 95%
CI 0.3 mm2, 0.0 mm2), which persisted after further146 AMERICAN JOURNAL OFadjustment for cardiometabolic risk factors (Model
3, 0.2 mm2, 95% CI 0.3 mm2, 0.0 mm2; 0.1 mm2,
95% CI 0.3 mm2, 0.0 mm2, respectively). While GS
showed little association with venular and arteriolar width,
arteriolar and venular tortuosity was reduced (3.9%, 95%
CI7.7%,0.1%;4.8%, 95%CI7.4%,2.1%, respec-
tively), even after adjustment for cardiometabolic risk fac-
tors (Model 3, 4.8%, 95% CI 8.7%, 0.7%; 4.8%,
95% CI 7.6%, 2.0%, respectively). Reduced arteriolar
and venular tortuosity were also associated with HTG and
NTG, but associations did not reach statistical significance
at the 5% level. The associations between OHT and retinal
vasculometry (both arteriolar and venular width and tortu-
osity) were null.
Sensitivity analyses, excluding those who self-reported
heart attack, stroke, type 2 diabetes, and hypertension,
resulted in fewer numbers (ie, 6,194 eyes from 3,516 partic-
ipants) but showed similar directions of association, with
HTGassociations with arteriolar and venular width remain-
ing (3.8 mm, 95% CI5.4 mm,2.3 mm;3.7 mm, 95%DECEMBER 2020OPHTHALMOLOGY
TABLE 3. Between-Eye Differences in Intraocular Pressure and Retinal Vessel Measures Among Individuals With the Same Diagnosis
in Each Eye
Both Eyes Classified as N
Average Between-Eye Differences, (SD) [95% CI]
IOPg IOPcc
Vessel Width (mm) Vessel Tortuosity (%) Vessel Area (mm2)
Arteriolar Venular Arteriolar Venular Arteriolar Venular
Unaffected 3,408 0.0 (2.3) 0.1 (2.9) 0.1 (6.0) 0.9 (10.3) 2.6 (1.4) 5.0 (1.4) 0.01 (0.68) 0.01 (0.63)
[0.1, 0.1] [0.2, 0.0] [0.3, 0.1] [0.6, 1.3] 2.6 (1.4) [6.0, 4.0] [0.01, 0.04] [0.04, 0.01]
HTG 32 0.1 (3.6) 0.0 (4.2) 1.0 (7.9) 1.6 (9.1) 3.9 (1.5) 6.8 (1.5) 0.00 (0.65) 0.07 (0.67)
[1.2, 1.4] [1.6, 1.5] [3.7, 1.8] [4.7, 1.6] [9.0, 18.7] [6.5, 22.0] [0.23, 0.23] [0.17, 0.31]
NTG 26 0.0 (2.9) 0.0 (3.4) 1.4 (9.4) 0.8 (8.1) 5.9 (1.4) 11.5 (1.5) 0.12 (0.68) 0.10 (0.76)
[1.2, 1.2] [1.4, 1.3] [5.1, 2.3] [2.4, 4.0] [17.3, 7.0] [23.6, 2.6] [0.39, 0.15] [0.20, 0.40]
GS 164 0.1 (3.1) 0.2 (3.4) 0.3 (7.2) 0.4 (11.1) 3.4 (1.4) 6.4 (1.4) 0.00 (0.71) 0.06 (0.57)
[0.5, 0.4] [0.7, 0.4] [1.3, 0.8] [2.0, 1.3] [8.0, 1.4] [10.7, 1.9] [0.11, 0.10] [0.15, 0.02]
OHT 193 0.5 (3.4) 0.7 (4.1) 0.5 (6.6) 1.1 (10.8) 3.3 (1.4) 4.2 (1.4) 0.05 (0.70) 0.01 (0.63)
[1.0, 0.0] [1.3, 0.1] [0.4, 1.4] [0.4, 2.6] [7.9, 1.5] [8.5, 0.2] [0.05, 0.15] [0.10, 0.07]
GS ¼ glaucoma suspect; HTG ¼ high-tension open-angle glaucoma; IOPcc ¼ corneal-compensated intraocular pressure; IOPg ¼
Goldmann-correlated intraocular pressure; N ¼ number of participants; NTG ¼ normal-tension glaucoma; OHT ¼ ocular hypertension.
For tortuosity the SD if the exponent of geometric SD.
FIGURE 3. Average between-eye differences in retinal vessel measures by quintiles of between-eye differences in Goldmann-
correlated intraocular pressure (IOP) among individuals who do not have a glaucoma diagnosis in either eye. R2 values from linear
regression using IOP as a continuous variable are less than 0.001 in all instances.CI 6.4 mm, 1.0 mm, respectively), and decreased arteri-
olar and venular tortuosity with GS (4.8%, 95%
CI 9.5%, 0.2%; 4.1%, 95% CI 7.4%, 0.6%,
respectively).
Among individuals with the same diagnosis in each eye,
arteriolar width marginally increased positively with IOP.
A similar pattern of association was observed among thoseVOL. 220 RETINAL VASCULOMETRY ASSOCunaffected by a glaucoma in either eye, GS in both eyes, or
OHT in both eyes. However, the pattern was less clear
among NTG and HTG patients, as the 95% CIs are wide
with small numbers of cases (Supplemental Figure 2; Sup-
plemental Material available at AJO.com). Table 3 sum-
marizes the between-eye asymmetry in IOP and retinal
vasculometry. Despite there being some evidence of147IATIONS WITH GLAUCOMA
asymmetry between the eyes, there was no evidence to sug-
gest that asymmetry in retinal vasculometry related to
between-eye differences in either Goldmann-correlated
IOP (Figure 3) or corneal-compensated IOP
(Supplemental Figure 3; Supplemental Material available
at AJO.com).
For participants with a different diagnosis between eyes,
there was no clear evidence of systematic within-person-
between-eye differences in retinal vasculometry
(Supplemental Table; Supplemental Material available at
AJO.com). The main subgroup pairs were as follows: unaf-
fected in 1 eye and OHT in the other (n¼ 288); unaffected
vs GS (n¼ 106); unaffected vs NTG (n¼ 10); NTG vs GS
(n ¼ 23); GS vs OHT (n ¼ 31); HTG vs GS (n ¼ 21).
Furthermore, between-eye differences in Goldmann-
correlated IOP were not related to between-eye differences
in retinal vasculometry, except for arteriolar area
(Supplemental Figure 4; Supplemental Material available
at AJO.com).DISCUSSION
IN THIS LARGE, EXTENSIVELY PHENOTYPED PREDOMI-
nantly White European cohort of middle-aged and older
men and women, we showed that an ocular diagnosis of
POAG (particularly HTG) was associated with reduced
retinal arteriolar and venular width, and also with reduced
venular area (which has been little studied to date).
Smaller venular and arteriolar tortuosity were also associ-
ated with a diagnosis of GS, suggesting that retinal vessel
tortuosity may be a cue to POAG development. The asso-
ciations identified in the present study persisted with
adjustment for factors related to ocular hemodynamics,
for cardiovascular and metabolic risk factors, and after
exclusion of those who self-reported cardiometabolic out-
comes, including heart attack, stroke, type 2 diabetes,
and hypertension.
The findings of reduced retinal arteriolar and venular
width associated with POAG are in keeping with a number
of population-based cross-sectional studies that have
observed arteriolar,9,13 venular, or both arteriolar and
venular narrowing associated with POAG.14,17 However,
vessel width associations have not been observed in all
studies.37 The orders of magnitude of arteriolar and venular
thinning in this study (approximately 2-3 mm on average,
with confidence intervals up to 6 mm) are commensurate
with other studies, although some studies have shown
mean differences in venular diameters of 10 mm or more,
but in relation to much larger central retinal vein equiva-
lent dimensions,14,17 which are double the magnitude of
the direct measures of venular width observed in this study
(ie,>200 mm vs<100mm). Given these different methods
of measurement, which have been previously shown to
have poor agreement, effect sizes will inevitably vary,148 AMERICAN JOURNAL OFlimiting direct comparisons across studies.38,39 Despite
this, we believe our findings are similar proportionately
and in absolute terms to other studies and are more likely
to be statistically significant, given the large number of
measures made (ie, with thousands of measures per eye).
Moreover, our study used measures obtained over the entire
retinal image, as opposed to measures restricted to peripa-
pillary concentric areas around the optic disc,9,13,14,17,37
with dimensions similar to studies that have reported direct
manual measures of peripapillary vessel widths,13 as
opposed to extrapolating to central retinal artery and
vein equivalents.9,13,14,17,37 Fewer population-based studies
have reported vessel width associations with other glau-
comatous outcomes, including GS and NTG.9,17 We found
evidence of vessel thinning with NTG, although the
magnitude of the difference was less than that observed
with high-tension POAG (HTG) and only statistically sig-
nificant for arterioles. Another study also showed vessel
thinning with NTG, but this was only statistically signifi-
cant for venules, suggesting that effect sizes might be
smaller and that greater numbers are needed to provide ev-
idence of effect.17
Taking our panretinal measurement approach, our find-
ings suggest that glaucomatous vasculometric features asso-
ciated with glaucoma are evident beyond previous, more
restrictive peripaillary measurement zones, affecting both
the macrovasculature and microvasculature and both arte-
rioles and venules. Our findings are novel in also showing
reduced venular area with glaucoma outcomes, and
decreased vessel tortuosity with suspect glaucoma, which
has been little studied to date. Reduced vessel tortuosity
has been observed with POAG in 1 other study (in addition
to other markers of vasculometry)18 as well as proxy
glaucoma-related outcomes, including reduced neuroreti-
nal rim area and RNFL thickness.40,41 An important
feature of tortuosity is that, unlike absolute quantification
of vessel width, measures were based on a ratio and hence
were dimensionless, potentially being interpretable across
different imaging systems. However, values are not directly
comparable, since methods for calculating tortuosity differ
and are not universal.
Another important consideration is whether vasculome-
try changes, and particularly novel associations observed
with retinal vessel tortuosity, occur as a cause or conse-
quence of glaucoma. The vasculogenesis of glaucoma is
supported by a number of systemic observations, including
glaucoma associations with increased tortuosity42 and
reduced blood flow in the capillary nail bed,43 and associa-
tions observed with vasospastic conditions, such as
migraine and Raynaud syndrome.44 However, biologically
it is unclear whether RNFL changes associated with glau-
coma result in vasoconstriction owing to reduced meta-
bolic need or whether changes in markers of ocular
perfusion/vasoautoregulation (including nitric oxide en-
zymes),45 leading to vascular dysregulation46,47 and/or
aqueous oxidative stress, precede glaucomatous RNFLDECEMBER 2020OPHTHALMOLOGY
changes.48 We argue that the novel between-eye analysis
included in the present study allows further examination
of cause and consequence. Within-person correlations of
vascular measures with IOP and/or glaucoma diagnosis
would be self-controlled for systemic cardiovascular risk
factors, lifestyle, medication, etc, and would therefore
tend to argue in favor of consequence at the eye level,
whereas the lack of within-person-between-eye correlation
observed in the present study suggests that systemic micro-
vascular changes, manifest in the retinal vessels but also
affecting other parts of the eye, are a more likely explana-
tion for the associations observed between glaucoma (or
raised IOP) and retinal vascular morphology at the
between-person level. In reality it is likely that the disease
process is a combination of both systemic and local factors
influencing the disease process. However, the analyses
would indicate whether systemic factors might precede
the disease process, in which case exploration of
between-person-within-eye differences in retinal vascul-
ometry prospectively with incident glaucoma cases would
be needed to test this hypothesis. Unfortunately, longitudi-
nal evidence from large population-based studies has been
sparse and provided equivocal evidence, showing prospec-
tive associations between retinal vasculometry and subse-
quent glaucoma diagnosis,15 or no association at all.16
While within-person-between-eye analyses could be
employed in other cross-sectional studies, especially given
that such analyses are well powered, further evidence
from longitudinal studies is needed to fully elucidate the
causal sequence of events.
The present study had a number of strengths and weak-
nesses worthy of consideration. A major strength was the
fully automated vasculometry system used (ie, QUARTZ),
which has been extensively validated28–31 and used to
provide a detailed retinal vasculometry phenotype for
this cohort,19 including novel characterization of vessel
tortuosity and area. Fully automated approaches are key
to large population study, where semiautomated/manual
approaches are prohibitively labor intensive and costly.
Although systemic markers may be risk factors for glau-
coma, glaucoma is a localized disease state. Hence, the an-
alytic approach was at an eye level, not at a person level, to
allow for eye-specific diagnoses. Previous approaches have
used a hierarchy to provide person-level diagnoses (even
when there are diagnostic differences between eyes),27
which could potentially dilute local effects in this context.
Accordingly, a person-based analysis using a hierarchy of
diagnoses, that is, where (1) POAG (HTG), (2) GS, and
(3) NTG are used in order of preference,27 showed similar
but weaker vasculometry effects (data not presented). A
major advantage of the EPIC-Norfolk cohort is that partic-
ipants are extensively phenotyped, allowing vasculometry
associations independent of potential confounders to be
gauged. We chose to adjust for axial length to allow for
the ocular magnification characteristics of participants,
and stature, as this is inversely related to open angle glau-VOL. 220 RETINAL VASCULOMETRY ASSOCcoma, as well as markers of ocular and systemic hemody-
namics.49,50 This is why the primary analysis also adjusted
for IOP and systolic blood pressure within this model,
which allowed the independence of associations to be
shown (particularly from blood pressure, where we have
shown definitively strong inverse associations with these
retinal vasculometric measures).33 The next model
included additional adjustment for established cardiovas-
cular andmetabolic risk factors, including total cholesterol,
HbA1c, BMI, and smoking status, to examine whether
retinal vasculometry associations with glaucoma were inde-
pendent of well-known precursors for cardiometabolic dis-
ease. This was confirmed in sensitivity analyses excluding
participants who self-reported heart attack, stroke, type 2
diabetes, and hypertension (many of which have been pro-
posed as putative risk factors for glaucoma), which further
showed persistence of the retinal vasculometry-glaucoma
associations observed. Moreover, we were able to fully ac-
count for any potential magnification effects of the imaging
system used.32
In terms of weaknesses, the present study, although
nested within a cohort, was cross-sectional, with the ocular
assessment only being part of the third clinical examina-
tion19; hence it was not possible to establish the temporal-
ity of association. Also, the current study was opportunistic
and not directly powered to detect within-person-between-
eye differences in retinal vasculometry associations with
glaucoma; hence a larger study might yield differences.
Longitudinal studies are needed, which only future
follow-up of the cohort would provide, and where there
would be increased power to discern effects, with more
events occurring owing to increased age.5 Moreover, it
would also be possible to examine potential ocular and sys-
temic antihypertensive treatment effects. Given the lack of
longitudinal follow-up, we can also not rule out that the as-
sociation of GS with arteriolar and venular tortuosity may
reflect a diagnostic bias, where those with straighter vessels
who may not go on to develop glaucoma are inadvertently
labeled. While the observation of similar directions of
vessel tortuosity associations with HTG and NTG would
argue against this, follow-up of the cohort establishing
those who convert to glaucoma is needed to formally
address this issue further. There were also too few closed-
angle glaucoma events to discern retinal vasculometry asso-
ciations, which may reflect the extensively white European
ancestry of the UK-based cohort, who are at lower risk.
Moreover, the cohort, although generalizable to the UK,
is somewhat select, which may infer a healthy volunteer
bias.27
We have provided evidence that the width, area, and
tortuosity of retinal vessels at a person level appear to be
affected by glaucoma. Similar magnitudes and directions
of association, particularly with vessel width, suggest that
both arterioles and venules are affected, and that vascular
effects are pervasive, not discriminatory. Moreover, the
absence of between-eye-within-person correlations in149IATIONS WITH GLAUCOMA
retinal vasculometry by diagnoses would appear to rule out
consequence, thereby suggesting that vasculometry
changes are indicative of systemic causal factors, which
could easily be confirmed in other cross-sectional studies.
However, in the absence of further longitudinal data we
are merely hypothesizing that our novel approach of
showing a lack of within-person-between-eye differences
in retinal vasculometry by glaucoma diagnosis in this
cross-sectional study provides further evidence (but not ab-
solute proof) of potential cause and effect. With the emer-
gence of artificial intelligence approaches to detect
glaucoma,51 vessel changes, in addition to other features,150 AMERICAN JOURNAL OFmay be key areas of interest to discern presence or absence
of disease, which can be more readily quantified compared
with visual interpretation (Figure 2). Saliency maps may
help in understanding the key features of the retinal image
that determine presence of disease, as they have done in
cardiovascular disease risk factor prediction.52 Such exam-
ination may reveal that retinal vessels are also key areas of
interest in glaucomatous development and, given the
limited value of IOP as a screening tool for glaucoma,27
vessel morphometry (particularly vessel tortuosity) may
provide a further simple cue to assist in glaucoma diagnoses
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